MARKET

MMED

MMED

MINIMED GROUP INC
NASDAQ
19.80
+0.69
+3.61%
Pre Market: 19.64 -0.16 -0.81% 09:03 10/09 EDT
OPEN
19.08
PREV CLOSE
19.11
HIGH
19.83
LOW
18.94
VOLUME
1.23K
TURNOVER
--
52 WEEK HIGH
24.43
52 WEEK LOW
10.65
MARKET CAP
5.57B
P/E (TTM)
-13.8510
1D
5D
1M
3M
1Y
5Y
1D
Largest borrow rate increases among liquid names
TipRanks · 3h ago
Medtronic Is Just 1 Year From Dividend King Status. Should You Buy the Stock Before It Gets There?
The Motley Fool · 23h ago
MiniMed Group Price Target Raised to $28.00/Share From $26.00 by Mizuho
Dow Jones · 1d ago
MiniMed Group Is Maintained at Outperform by Mizuho
Dow Jones · 1d ago
Mizuho Maintains Outperform on Minimed Group, Raises Price Target to $28
Benzinga · 1d ago
MiniMed price target raised to $28 from $26 at Mizuho
TipRanks · 1d ago
Jim Cramer Doesn’t Like This Health Care Stock, Sees No Reason To Buy Rambus
Benzinga · 1d ago
Medtronic Finalizes 4.5939 Exchange Ratio As MiniMed Split-Off Nears Completion
NASDAQ · 1d ago
More
About MMED
MiniMed Group, Inc. is a medical technology company, which develops, manufactures, and markets a comprehensive suite of solutions for the management of diabetes. Its fully integrated system addresses pain points for people with diabetes (PWD): health outcomes and complexity of diabetes management. The MiniMed 780G is its flagship AID system. The MiniMed 780G system uses its SmartGuard dosing algorithm technology, which automatically delivers basal insulin and auto-correction doses every five minutes based on sensor glucose readings. The MiniMed 780G consists of the MiniMed 780G insulin pump, the Simplera Sync CGM sensor, and the instinct sensor. Its platform of clinically effective solutions for PWD requiring insulin therapy includes Automated Insulin Delivery (AID) Systems and a Smart Multiple Daily Injection (MDI) System. Its pipeline products are the MiniMed Flex, screenless insulin pump, next-generation Vivera dosing algorithm, and MiniMed Fit patch pump with extended wear.

Webull offers MiniMed Group, Inc. stock information, including NASDAQ: MMED real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MMED stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading MMED stock methods without spending real money on the virtual paper trading platform.